Understanding pouch procedures and why pouches may fail: Can we redo or should we not redo failed pouches?

Robert M. Strauss, MD, gastroenterologist, GI Specialists of Georgia, gives an overview of the characteristics and pathology of Clostridium difficile. He explains that when the population of good...

Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.

In this video, Karen Onel, MD, previews the ACR guideline for the management of juvenile idiopathic arthritis, which addresses treatments for systemic JIA, oligoarthritis, and TMJ arthritis.

David R. Nelson, MD, discusses future developments to HCV treatment strategies and methods, and how they will affect the standard of care.